Takeda Pharmaceutical Company Limited Adjustments For Decrease Increase In Trade And Other Receivables
Takeda Pharmaceutical Company Limited (TAK) reported Adjustments For Decrease Increase In Trade And Other Receivables of -JPY 58.96 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables · last filed 2025-06-25
| Period end | Adjustments For Decrease Increase In Trade And Other Receivables 12 month |
|---|---|
| 2025-03-31 | -58.96B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 15.10B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 75.13B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 127.29B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | -9.32B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | -34.83B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | -13.38B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | -647.00M JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | -37.31B JPY 20-F · filed 2019-06-27 |